BACKGROUND: There is now sufficient demand for bariatric surgery to compare bariatric surgeons and bariatric centers according to their postsurgical outcomes, but few validated risk stratification measures are available to enable valid comparisons. The purpose of this study was to develop and validate a risk stratification model of composite adverse events related to Roux-en-Y gastric bypass (RYGB) surgery. METHODS: The study population included 36,254 patients from the Bariatric Outcomes Longitudinal Database (BOLD) registry who were 18-70 years old and had RYGB between June 11, 2007, and December 2, 2009. This population was randomly divided into a 50% testing sample and a 50% validation sample. The testing sample was used to identify significant predictors of 90-day composite adverse events and estimate odds ratios, while the validation sample was used to assess model calibration. After validating the fit of the risk stratification model, the testing and validation samples were combined to estimate the final odds ratios. RESULTS: The 90-day composite adverse event rate was 1.48%. The risk stratification model of 90-day composite adverse events included age (40-64, ≥ 65), indicators for male gender, body mass index (50-59.9, ≥ 60), obesity hypoventilation syndrome, back pain, diabetes, pulmonary hypertension, ischemic heart disease, functional status, and American Society of Anesthesiology classes 4 or 5. Our final gastric bypass model was predictive (c-statistic = .68) of serious adverse events 90 days after surgery. CONCLUSIONS: With additional validation, this risk model can inform both the patient and surgeon about the risks of bariatric surgery and its different procedures, as well as enable valid outcomes comparisons between surgeons and surgical programs. Published by Elsevier Inc.
BACKGROUND: There is now sufficient demand for bariatric surgery to compare bariatric surgeons and bariatric centers according to their postsurgical outcomes, but few validated risk stratification measures are available to enable valid comparisons. The purpose of this study was to develop and validate a risk stratification model of composite adverse events related to Roux-en-Y gastric bypass (RYGB) surgery. METHODS: The study population included 36,254 patients from the Bariatric Outcomes Longitudinal Database (BOLD) registry who were 18-70 years old and had RYGB between June 11, 2007, and December 2, 2009. This population was randomly divided into a 50% testing sample and a 50% validation sample. The testing sample was used to identify significant predictors of 90-day composite adverse events and estimate odds ratios, while the validation sample was used to assess model calibration. After validating the fit of the risk stratification model, the testing and validation samples were combined to estimate the final odds ratios. RESULTS: The 90-day composite adverse event rate was 1.48%. The risk stratification model of 90-day composite adverse events included age (40-64, ≥ 65), indicators for male gender, body mass index (50-59.9, ≥ 60), obesity hypoventilation syndrome, back pain, diabetes, pulmonary hypertension, ischemic heart disease, functional status, and American Society of Anesthesiology classes 4 or 5. Our final gastric bypass model was predictive (c-statistic = .68) of serious adverse events 90 days after surgery. CONCLUSIONS: With additional validation, this risk model can inform both the patient and surgeon about the risks of bariatric surgery and its different procedures, as well as enable valid outcomes comparisons between surgeons and surgical programs. Published by Elsevier Inc.
Authors: K Hope Wilkinson; Melissa Helm; Kathleen Lak; Rana M Higgins; Jon C Gould; Tammy L Kindel Journal: Obes Surg Date: 2019-09 Impact factor: 4.129
Authors: Noëlle Geubbels; L Maurits de Brauw; Yair I Z Acherman; Arnold W J M van de Laar; Sjoerd C Bruin Journal: Obes Surg Date: 2015-12 Impact factor: 4.129
Authors: Felix Nickel; Javier R de la Garza; Fabian S Werthmann; Laura Benner; Christian Tapking; Emir Karadza; Anna-Laura Wekerle; Adrian T Billeter; Hannes G Kenngott; Lars Fischer; Beat Peter Müller-Stich Journal: Obes Facts Date: 2019-08-15 Impact factor: 3.942
Authors: Hugo Meunier; Benjamin Menahem; Yannick Le Roux; Adrien Lee Bion; Yoann Marion; Antoine Vallois; Nicolas Contival; Thomas Gautier; Jean Lubrano; Anaïs Briant; Jean-Jacques Parienti; Arnaud Alves Journal: Obes Surg Date: 2021-04-28 Impact factor: 4.129
Authors: G Fantola; P L Nguyen-Thi; N Reibel; M A Sirveaux; A Germain; A Ayav; L Bresler; R Zarnegar; L Brunaud Journal: Obes Surg Date: 2015-07 Impact factor: 4.129
Authors: Raquel Sánchez-Santos; Ricard Corcelles Codina; Ramon Vilallonga Puy; Salvadora Delgado Rivilla; Jose Vicente Ferrer Valls; Javier Foncillas Corvinos; Carlos Masdevall Noguera; Maria Socas Macias; Pedro Gomes; Carmen Balague Ponz; Jorge De Tomas Palacios; Sergio Ortiz Sebastian; Andres Sanchez-Pernaute; Jose Julian Puche Pla; Daniel Del Castillo Dejardin; Julen Abasolo Vega; Ester Mans Muntwyler; Ana Garcia Navarro; Carlos Duran Escribano; Norberto Cassinello Fernández; Nieves Perez Climent; Jose Antonio Gracia Solanas; Francisca Garcia-Moreno Nisa; Alberto Hernández Matias; Victor Valentí Azcarate; Jose Eduardo Perez Folques; Inmaculada Navarro Garcia; Eduardo Dominguez-Adame Lanuza; Sagrario Martinez Cortijo; Jesus González Fernández Journal: Obes Surg Date: 2016-12 Impact factor: 4.129